Mirum to report Phase 3 EXPAND topline data for LIVMARLI in ultra-rare cholestatic liver diseases Oct. 12
Bitget2026/10/11 21:00- Mirum scheduled an investor call for Oct. 12, 2026 to present topline Phase 3 EXPAND results for LIVMARLI in ultra-rare cholestatic liver diseases.
- Data will cover treatment of cholestatic pruritus in patients aged 6 months or older, including biliary atresia.
- Results have not yet been presented; the company plans to disclose them during the call.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
No breakthrough in talks at Antofagasta’s striking Centinela copper mine, unions say

U.S. commercial crude oil inventories fell more than expected, with distillate inventories also declining and gasoline unexpectedly rising.
According to EIA data released on Thursday, for the week ending October 9, U.S. commercial crude oil inventories decreased by 8.6 million barrels to 415.6 million barrels, about 3% below the five-year average for the same period. Crude oil production fell by 300,000 barrels per day, and imports dropped by 791,000 barrels per day. Refinery crude runs increased by 135,000 barrels per day. Gasoline inventories rose by 3.5 million barrels, exceeding expectations, while distillate fuel inventories (including diesel and heating oil) decreased by 2.5 million barrels. The decline in crude inventories was mainly due to production shutdowns and reduced imports caused by a Gulf of Mexico hurricane.
